Please find all related articles below.
“Placing pharma policy in DG Enterprise was justified. It has traditionally been in DG Enterprise, but was moved to DG Sanco and has once again been instated as an Enterprise competence” said during her hearing Commissioner-designate Elzbieta Bienkowska.
By Dorota Sienkiewicz,Health Equity and Policy Coherence Coordinator, and Martyna Giedrojć, EPHA Policy Officer for Health Systems
The pharmaceutical industry is the biggest sector in the world. In terms of production, (...)
Brussels, 2 October 2014 - We are writing to support Member States who have already expressed their concerns on the decision of European Commission President Elect Jean-Claude Juncker to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of Internal Market and Industry within the new Commission. We would like to ask for your full support to have that decision reversed.
Dear Head of States, Dear Prime (...)
Elżbieta Bieńkowska (born on 4 February 1964 in Katowice, Poland) became the Minister of Regional Development in the Cabinet of the Prime Minister Donald Tusk between 2007 and 2013 in Poland. She was then appointed a Deputy Prime Minister and carried out her mandate at the Ministry of Infrastructure and Development. In 2014 she has been nominated by the Polish government for European Commissioner who has received the Internal Market, Industry, Entrepreneurship and SMEs portfolio (...)
The fifth international influenza conference organised by EPHA member the European Scientific Working Group on Influenza (ESWI) took place in Riga on 14-17 September. A number of plenary and ’science/policy interface’ sessions examined the issue of low vaccination uptake in many Member States, as well as other issues related to pandemic preparedness and communication aspects of influenza-related health threats.
In the opening plenary, ’Why should influenza be a public (...)
The issue of medicine supply shortages has been highlighted by EPHA and its members throughout 2013, and it once again took centre stage at a recent workshop organised by the European Association of Hospital Pharmacists (EAHP). Already in winter, a common position on the issue has been drafted by members of the European Medicine Agency’s Patients’ and Consumers’ / Healthcare Professionals Working Party.
2014 EAHP Congress, Barcelona
The 19th annual EAHP (...)
Access to Medicines
Pharmaceuticals and Medicines
Vaccines and Immunization
Antimicrobial Resistance (AMR)
The global problem of Antimicrobial Resistance (AMR) demands the continuous attention of the public health community beyond the annual focus of the European Antibiotic Awareness Day (marked annually on 18 November). EPHA is committed to raising awareness of AMR-related concerns, including the reduction of antibiotics use, to ensure that people living in Europe can continue to benefit from life-saving antibiotics. Moreover, it is important to promote policy coherence, as well as effective, (...)
Last week, more than 150 NGOs from the US and EU sent a letter to Commissioner De Gucht and US Ambassador Michael Froman explaining their deep concerns about proposals for "regulatory cooperation". A similar letter was sent on 19 May 2014 by a group of Brussels based NGOs have petitoning Commissioner De Gucht for full transparency on the Transatlantic Trade and Investment Partnership (TTIP) negotiations.
The letter raises EU’s civil society deep concerns about the lack of (...)
On 12 May 2014 several NGOs from both sides of the Atlantic sent a letter to the EU Trade Commissioner Karel De Gucht and the US Ambassador Michael Froman spelling out their concerns on proposals for "regulatory cooperation" between the United States and European Union under the Trans-Atlantic Trade and Investment Partnership (TTIP).
It is remarkable that EU and US negotiators have turned a technical issue into the trending topic of the year. The clear lack of transparency that (...)
On 27 March, the European Commission (EC) launched a public consultation on the investor-state dispute settlement (ISDS) chapter within the context of the Transatlantic (ie EU-US) Trade and Investment Partnership (TTIP). Weeks earlier, the EU Trade Commissioner put a halt to negotiations over the ISDS due to mounting criticism from civil society groups and the European Parliament (EP).
07 April 2014 - This consultation has been presented by the EC as a solution to increase transparency (...)
In December 2013, the European Commission launched a public consultation on patient safety and quality of care in the EU, which ran until the end of February 2014. As Europe’s leading NGO advocating for better health, EPHA contributed to this consultation and provided the Commission with the online questionnaire and a letter.
The consultation was aimed at seeking the opinion of civil society on:
Whether patient safety measures included in the Recommendation 2009 have been (...)